NEWS & PERSPECTIVES

Psychedelics News

Curated updates on microdosing, research, policy, and community.

The latest

2025-04-24 • Psychedelics Today

Psychedelic Science 2025: A Convergence of Data, Discovery, and Integration

On June 16, 2025, thousands of researchers, clinicians, therapists, policymakers, and advocates will converge in Denver, Colorado, for Psychedelic Science 2025: The Integration, the world’s most important gathering fo...

2025-04-23 • ScienceDaily Psychedelics

Psychedelics can reverse neuroimmune interactions that boost fear

A new study suggests that fear and the immune system are connected in previously unknown ways. Researchers found that the immune system can influence stress and fear behaviors by changing how brain cells communicate.

2025-04-22 • Psychedelics Today

Zach Leary – Your Extraordinary Mind

In this special Bicycle Day episode, Joe Moore and Kyle Buller sit down in person with author and podcaster Zach Leary to discuss his new book, Your Extraordinary Mind: Psychedelics in the 21st Century and How to Use ...

2025-04-22 • ScienceDaily Psychedelics

More Americans are using psilocybin -- especially those with mental health conditions, study shows

Use of psilocybin, the hallucinogenic chemical found in what is known as 'magic mushrooms,' has increased significantly nationwide since 2019, according to a new study.

2025-04-17 • PsyMed Ventures

What's wrong with US healthcare and how startups can fix it, with Justin Mares

Business Trip by PsyMed Ventures, a podcast exploring the future of mental and brain health & the startups building it

2025-04-17 • Psychedelics Today

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

In this episode, Joe Moore welcomes LP Giobbi, an internationally famous DJ, electronic music producer, and jazz pianist. LP shares the story behind Dead House, her project blending Grateful Dead samples with hou...

2025-04-16 • Psychedelics Today

Psychedelic Science 2025

Psychedelic Science 2025 is the world’s largest gathering focused on psychedelic research, policy, therapy, and culture. Hosted in Denver, Colorado, this landmark event brings together leading scientists, therapists, ...

2025-04-16 • Psychedelics Today

Oakland Psychedelic Conference

Oakland Hosts Historic Psychedelic and Spirituality Gathering This Weekend This weekend, Oakland becomes the epicenter of psychedelic and spiritual exploration with the two-day event: Oakland ...

2025-04-15 • Psychedelics Today

Kayse Gehret – The Modern Guide: Microdosing, Facilitation & Community

In this episode, Kyle Buller speaks with Kayse Geheret, founder of Microdosing for Healing and instructor for Psychedelics Today’s Vital program. They explore what it means to be a modern guide in the world of psyched...

2025-04-14 • ScienceDaily Psychedelics

LSD analogue with potential for treating schizophrenia developed

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

2025-04-11 • Breaking Convention (Substack)

Saturday Day tickets now on sale!

And, Saturday night accommodation discount!!!

2025-03-26 • Breaking Convention (Substack)

100+ speakers confirmed for Breaking Convention 2025!

Names and talk titles for your delight

2025-03-07 • Psymposia

Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia

Rather than unpacking the actual causes of Lykos Therapeutics' disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public ...

2025-03-07 • Psymposia

Correcting the Record: What The New York Times Got Wrong

In response to the The New York Times February 4 article, "How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy," Psymposia requested corrections to numerous errors and false accusations. The po...

2025-03-05 • ScienceDaily Psychedelics

Compound harnesses cannabis' pain-relieving properties without side effects

Researchers have developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The custom-designed molecule, derived from cannabis, may ...